2007Journal of clinical and experimental medicineRequires access

Trimetazidine for unstable angina pectoris

Sun Jianhu

Open publisher page 0 citations

Abstract

Objective To investigate the therapeutic results of trimetazidine for unstable angina pectoris(UAP).Methods 47 patients with UAP were randomly assigned to receive trimetazidine in addition to conventional therapy for 4 weeks(n=23)or conventional therapy consisting of nitrate,β-blocker and aspirin(n=24,control group).Clinical effectiveness and changes in electrocardiogram,heart rate and blood pressure were evaluated.Results The clinical effectiveness was significantly better in trimetazidine group patients than in control group patients(P0.01).The differences in frequency and duration of angina attack were statistically different before and after treatment in both groups of patients(P0.05).The differences in frequency and duration of angina attack were statistically different after treatment between two groups(P0.05).Trimetazidine had no significant effect on heart rate and blood pressure.Conclusion Trimetazidine is useful for UAP,and deserves recommendation.

About this research paper

What this paper is about

Objective To investigate the therapeutic results of trimetazidine for unstable angina pectoris(UAP).Methods 47 patients with UAP were randomly assigned to receive trimetazidine in addition to conventional therapy for 4 weeks(n=23)or conventional therapy consisting of nitrate,β-blocker and aspirin(n=24,control group).Clinical effectiveness and changes in electrocardiogram,heart rate and blood pressure were evaluated.Results The clinical effectiveness was significantly better in trimetazidine group patients than in control group patients(P0.01).The differences in frequency and duration of angina attack were statistically different before and after treatment in both groups of patients(P0.05).The differences in frequency and duration of angina attack were statistically different after treatment between two groups(P0.05).Trimetazidine had no significant effect on heart rate and blood pressure.Conclusion Trimetazidine is useful for UAP,and deserves recommendation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic results of trimetazidine for unstable angina pectoris(UAP).Methods 47 patients with UAP were randomly assigned to receive trimetazidine in addition to conventional therapy for 4 weeks(n=23)or conventional therapy consisting of nitrate,β-blocker and aspirin(n=24,control group).Clinical effectiveness and changes in electrocardiogram,heart rate and blood pressure were evaluated.Results The clinical effectiveness was significantly better in trimetazidine group patients than in control group patients(P0.01).The differences in frequency and duration of angina attack were statistically different before and after treatment in both groups of patients(P0.05).The differences in frequency and duration of angina attack were statistically different after treatment between two groups(P0.05).Trimetazidine had no significant effect on heart rate and blood pressure.Conclusion Trimetazidine is useful for UAP,and deserves recommendation.

Key concepts: Trimetazidine, Medicine, Cardiology, Unstable angina, Blood pressure, Angina, Internal medicine, Aspirin

Related papers

Back to paper searchBrowse research topicsOriginal source
Trimetazidine for unstable angina pectoris — Research Paper | ScholarLens